Texas AG sues Pfizer over quality-control lapses in kids' ADHD drug
By Brendan Pierson Texas Attorney General Ken Paxton accused Pfizer and its supplier Tris Pharma of providing children's
2023-11-21 08:47
Pfizer swings to loss as COVID product demand slump sparks charges
(Reuters) -Pfizer on Tuesday reported its first quarterly loss since 2019, as demand fell for its COVID products and it
2023-10-31 19:53
BioNTech will likely take 900 million eur write-off on Pfizer-partnered vaccines
BERLIN Germany's BioNTech on Monday said it would likely take write-downs of up to 900 million euros ($947
2023-10-16 16:17
Pfizer lowers full-year revenue forecast, shares fall
Pfizer Inc on Friday cut forecast for 2023 revenue to between $58 billion and $61 billion, from $67
2023-10-14 04:59
EU antitrust regulators set Oct. 19 deadline for Pfizer's Seagen deal
BRUSSELS Pfizer's $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a
2023-09-16 02:21
Pfizer's production facilities appear undamaged in N. Carolina tornado, CEO says
Pfizer CEO Albert Bourla said on Friday that hurricane damage this week had almost completely destroyed the drugmaker's
2023-07-22 02:58
US FTC seeks additional info on Pfizer's proposed takeover of Seagen
(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and documentary material related to Pfizer's proposed acquisition of
2023-07-15 05:52
Former Pfizer employee charged with Covid drug insider trading
The US Securities and Exchange Commission on Thursday charged a former Pfizer employee and his friend for trading on insider information regarding the success of the company's trial for Paxlovid, its Covid antiviral drug.
2023-06-30 02:55
Pfizer plans to raise $31 billion from debt offering to finance Seagen takeover
Pfizer Inc said on Tuesday it plans to raise $31 billion from a debt offering to finance its
2023-05-17 07:52
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head'
By Michael Erman and Bhanvi Satija NEW YORK (Reuters) -Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate
2023-05-12 06:18